Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Neuroinflammation
Published in: Journal of Neuroinflammation 1/2024

Open Access 01-12-2024 | Diabetic Retinopathy | Research

The glucocorticoid receptor as a master regulator of the Müller cell response to diabetic conditions in mice

Authors: Anna M. Pfaller, Lew Kaplan, Madalena Carido, Felix Grassmann, Nundehui Díaz-Lezama, Farhad Ghaseminejad, Kirsten A. Wunderlich, Sarah Glänzer, Oliver Bludau, Thomas Pannicke, Bernhard H. F. Weber, Susanne F. Koch, Boyan Bonev, Stefanie M. Hauck, Antje Grosche

Published in: Journal of Neuroinflammation | Issue 1/2024

Login to get access

Abstract

Diabetic retinopathy (DR) is considered a primarily microvascular complication of diabetes. Müller glia cells are at the centre of the retinal neurovascular unit and play a critical role in DR. We therefore investigated Müller cell-specific signalling pathways that are altered in DR to identify novel targets for gene therapy. Using a multi-omics approach on purified Müller cells from diabetic db/db mice, we found the mRNA and protein expression of the glucocorticoid receptor (GR) to be significantly decreased, while its target gene cluster was down-regulated. Further, oPOSSUM TF analysis and ATAC- sequencing identified the GR as a master regulator of Müller cell response to diabetic conditions. Cortisol not only increased GR phosphorylation. It also induced changes in the expression of known GR target genes in retinal explants. Finally, retinal functionality was improved by AAV-mediated overexpression of GR in Müller cells. Our study demonstrates an important role of the glial GR in DR and implies that therapeutic approaches targeting this signalling pathway should be aimed at increasing GR expression rather than the addition of more ligand.

Graphical Abstract

Appendix
Available only for authorised users
Literature
1.
2.
3.
Sohn EH, van Dijk HW, Jiao C, Kok PH, Jeong W, Demirkaya N, et al. Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. Proc Natl Acad Sci USA. 2016;113(19):E2655–64.PubMedPubMedCentralCrossRef
4.
Brooks HL Jr, Caballero S Jr, Newell CK, Steinmetz RL, Watson D, Segal MS, et al. Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone. Arch Ophthalmol. 2004;122(12):1801–7.PubMedCrossRef
5.
Itakura H, Akiyama H, Hagimura N, Doi H, Tanaka T, Kishi S, et al. Triamcinolone acetonide suppresses interleukin-1 beta-mediated increase in vascular endothelial growth factor expression in cultured rat Muller cells. Graefes Arch Clin Exp Ophthalmol. 2006;244(2):226–31.PubMedCrossRef
6.
Wurm A, Iandiev I, Hollborn M, Wiedemann P, Reichenbach A, Zimmermann H, et al. Purinergic receptor activation inhibits osmotic glial cell swelling in the diabetic rat retina. Exp Eye Res. 2008;87(4):385–93.PubMedCrossRef
7.
Wirostko B, Wong TY, Simo R. Vascular endothelial growth factor and diabetic complications. Prog Retin Eye Res. 2008;27(6):608–21.PubMedCrossRef
8.
Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414(6865):813–20.ADSPubMedCrossRef
9.
10.
Bringmann A, Grosche A, Pannicke T, Reichenbach A. GABA and glutamate uptake and metabolism in retinal glial (Muller) cells. Front Endocrinol (Lausanne). 2013;4:48.PubMedCrossRef
11.
Wurm A, Pannicke T, Iandiev I, Francke M, Hollborn M, Wiedemann P, et al. Purinergic signaling involved in Muller cell function in the mammalian retina. Prog Retin Eye Res. 2011;30(5):324–42.PubMedCrossRef
12.
Bringmann A, Pannicke T, Grosche J, Francke M, Wiedemann P, Skatchkov SN, et al. Muller cells in the healthy and diseased retina. Prog Retin Eye Res. 2006;25(4):397–424.PubMedCrossRef
13.
14.
Shen W, Fruttiger M, Zhu L, Chung SH, Barnett NL, Kirk JK, Lee S, Coorey NJ, Killingsworth M, Sherman LS, Gillies MC. Conditional Müllercell ablation causes independent neuronal and vascular pathologies in a novel transgenic model. J Neurosci. 2012;32(45):15715–27. https://​doi.​org/​10.​1523/​JNEUROSCI.​2841-12.​2012
15.
Li Q, Puro DG. Diabetes-induced dysfunction of the glutamate transporter in retinal Muller cells. Invest Ophthalmol Vis Sci. 2002;43(9):3109–16.PubMed
16.
Lieth E, LaNoue KF, Antonetti DA, Ratz M. Diabetes reduces glutamate oxidation and glutamine synthesis in the retina. The Penn State Retina Research Group. Exp Eye Res. 2000;70(6):723–30.PubMedCrossRef
17.
Pannicke T, Iandiev I, Wurm A, Uckermann O, vom Hagen F, Reichenbach A, et al. Diabetes alters osmotic swelling characteristics and membrane conductance of glial cells in rat retina. Diabetes. 2006;55(3):633–9.PubMedCrossRef
18.
Bringmann A, Pannicke T, Uhlmann S, Kohen L, Wiedemann P, Reichenbach A. Membrane conductance of Muller glial cells in proliferative diabetic retinopathy. Can J Ophthalmol. 2002;37(4):221–7.PubMedCrossRef
19.
Baumann B, Sterling J, Song Y, Song D, Fruttiger M, Gillies M, et al. Conditional Muller cell ablation leads to retinal iron accumulation. Invest Ophthalmol Vis Sci. 2017;58(10):4223–34.PubMedPubMedCentralCrossRef
20.
Maharaj AS, Walshe TE, Saint-Geniez M, Venkatesha S, Maldonado AE, Himes NC, et al. VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma. J Exp Med. 2008;205(2):491–501.PubMedPubMedCentralCrossRef
21.
Ford KM, Saint-Geniez M, Walshe T, Zahr A, D’Amore PA. Expression and role of VEGF in the adult retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2011;52(13):9478–87.PubMedPubMedCentralCrossRef
22.
Dossarps D, Bron AM, Koehrer P, Aho-Glele LS, Creuzot-Garcher C, Net F. Endophthalmitis after intravitreal injections: incidence, presentation, management, and visual outcome. Am J Ophthalmol. 2015;160(1):17–251.PubMedCrossRef
23.
Das A, Stroud S, Mehta A, Rangasamy S. New treatments for diabetic retinopathy. Diabetes Obes Metab. 2015;17(3):219–30.PubMedCrossRef
24.
Semeraro F, Morescalchi F, Cancarini A, Russo A, Rezzola S, Costagliola C. Diabetic retinopathy, a vascular and inflammatory disease: therapeutic implications. Diabetes Metab. 2019;45(6):517–27.PubMedCrossRef
25.
Gallina D, Zelinka C, Fischer AJ. Glucocorticoid receptors in the retina, Muller glia and the formation of Muller glia-derived progenitors. Development. 2014;141(17):3340–51.PubMedPubMedCentralCrossRef
26.
Schaaf MJ, Cidlowski JA. Molecular mechanisms of glucocorticoid action and resistance. J Steroid Biochem Mol Biol. 2002;83(1–5):37–48.PubMedCrossRef
27.
Yeager MP, Pioli PA, Guyre PM. Cortisol exerts bi-phasic regulation of inflammation in humans. Dose Response. 2011;9(3):332–47.PubMedCrossRef
28.
Roy MS, Roy A, Brown S. Increased urinary-free cortisol outputs in diabetic patients. J Diabetes Complicat. 1998;12(1):24–7.CrossRef
29.
Chiodini I, Adda G, Scillitani A, Coletti F, Morelli V, Di Lembo S, et al. Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications. Diabetes Care. 2007;30(1):83–8.PubMedCrossRef
30.
Vandevyver S, Dejager L, Libert C. Comprehensive overview of the structure and regulation of the glucocorticoid receptor. Endocr Rev. 2014;35(4):671–93.PubMedCrossRef
31.
Gallina D, Zelinka CP, Cebulla CM, Fischer AJ. Activation of glucocorticoid receptors in Muller glia is protective to retinal neurons and suppresses microglial reactivity. Exp Neurol. 2015;273:114–25.PubMedPubMedCentralCrossRef
32.
Shen W, Lee SR, Araujo J, Chung SH, Zhu L, Gillies MC. Effect of glucocorticoids on neuronal and vascular pathology in a transgenic model of selective Muller cell ablation. Glia. 2014;62(7):1110–24.PubMedCrossRef
33.
Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell. 1996;84(3):491–5. https://​doi.​org/​10.​1016/​s0092-8674(00)81294-5.
34.
Hammer SS, Vieira CP, McFarland D, Sandler M, Levitsky Y, Dorweiler TF, Lydic TA, Asare-Bediako B, Adu-Agyeiwaah Y, Sielski MS, Dupont M, Longhini AL, Li Calzi S, Chakraborty D, Seigel GM, Proshlyakov DA, Grant MB, Busik JV. Fasting and fasting-mimicking treatment activate SIRT1/LXRα and alleviate diabetes-induced systemic and microvascular dysfunction. Diabetologia. 2021;64(7):1674–89. https://​doi.​org/​10.​1007/​s00125-021-05431-5.
35.
Coleman DL, Hummel KP. Hyperinsulinemia in pre-weaning diabetes (db) mice. Diabetologia. 1974;10(Suppl):607–10.PubMedCrossRef
36.
37.
Majimbi M, McLenachan S, Nesbit M, Chen FK, Lam V, Mamo J, et al. In vivo retinal imaging is associated with cognitive decline, blood–brain barrier disruption and neuroinflammation in type 2 diabetic mice. Front Endocrinol (Lausanne). 2023;14:1224418.PubMedCrossRef
38.
Kjorholt C, Akerfeldt MC, Biden TJ, Laybutt DR. Chronic hyperglycemia, independent of plasma lipid levels, is sufficient for the loss of beta-cell differentiation and secretory function in the db/db mouse model of diabetes. Diabetes. 2005;54(9):2755–63.PubMedCrossRef
39.
Tonra JR, Ono M, Liu X, Garcia K, Jackson C, Yancopoulos GD, et al. Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice. Diabetes. 1999;48(3):588–94.PubMedCrossRef
40.
Midena E, Segato T, Radin S, di Giorgio G, Meneghini F, Piermarocchi S, et al. Studies on the retina of the diabetic db/db mouse. I. Endothelial cell-pericyte ratio. Ophthalmic Res. 1989;21(2):106–11.PubMedCrossRef
41.
Hanaguri J, Yokota H, Watanabe M, Yamagami S, Kushiyama A, Kuo L, et al. Retinal blood flow dysregulation precedes neural retinal dysfunction in type 2 diabetic mice. Sci Rep. 2021;11(1):18401.ADSPubMedPubMedCentralCrossRef
42.
Xiao C, He M, Nan Y, Zhang D, Chen B, Guan Y, et al. Physiological effects of superoxide dismutase on altered visual function of retinal ganglion cells in db/db mice. PLoS ONE. 2012;7(1): e30343.ADSPubMedPubMedCentralCrossRef
43.
Li J, Wang JJ, Yu Q, Chen K, Mahadev K, Zhang SX. Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice: role of NADPH oxidase 4. Diabetes. 2010;59(6):1528–38.PubMedPubMedCentralCrossRef
44.
Yang Q, Xu Y, Xie P, Cheng H, Song Q, Su T, et al. Retinal neurodegeneration in db/db mice at the early period of diabetes. J Ophthalmol. 2015;2015: 757412.PubMedPubMedCentralCrossRef
45.
Cheung AK, Fung MK, Lo AC, Lam TT, So KF, Chung SS, et al. Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. Diabetes. 2005;54(11):3119–25.PubMedCrossRef
46.
47.
Roesch K, Stadler MB, Cepko CL. Gene expression changes within Muller glial cells in retinitis pigmentosa. Mol Vis. 2012;18:1197–214.PubMedPubMedCentral
48.
Sigurdsson D, Grimm C. Single-cell transcriptomic profiling of muller glia in the rd10 retina. Adv Exp Med Biol. 2023;1415:377–81.PubMedCrossRef
49.
Chen K, Wang Y, Huang Y, Liu X, Tian X, Yang Y, et al. Cross-species scRNA-seq reveals the cellular landscape of retina and early alterations in type 2 diabetes mice. Genomics. 2023;115(4): 110644.PubMedCrossRef
50.
Lee ES, Lee JY, Jeon CJ. Types and density of calretinin-containing retinal ganglion cells in mouse. Neurosci Res. 2010;66(2):141–50.PubMedCrossRef
51.
Lee SC, Weltzien F, Madigan MC, Martin PR, Grunert U. Identification of AII amacrine, displaced amacrine, and bistratified ganglion cell types in human retina with antibodies against calretinin. J Comp Neurol. 2016;524(1):39–53.PubMedCrossRef
52.
53.
Lyu Q, Xu S, Lyu Y, Choi M, Christie CK, Slivano OJ, et al. SENCR stabilizes vascular endothelial cell adherens junctions through interaction with CKAP4. Proc Natl Acad Sci USA. 2019;116(2):546–55.ADSPubMedCrossRef
54.
Ghinia Tegla MG, Buenaventura DF, Kim DY, Thakurdin C, Gonzalez KC, Emerson MM. OTX2 represses sister cell fate choices in the developing retina to promote photoreceptor specification. Elife. 2020;9.
55.
Grosche A, Hauser A, Lepper MF, Mayo R, von Toerne C, Merl-Pham J, et al. The proteome of native adult muller glial cells from murine retina. Mol Cell Proteomics. 2016;15(2):462–80.PubMedCrossRef
56.
57.
Kwon AT, Arenillas DJ, Worsley Hunt R, Wasserman WW. oPOSSUM-3: advanced analysis of regulatory motif over-representation across genes or ChIP-Seq datasets. G3 (Bethesda). 2012;2(9):987–1002.PubMedPubMedCentralCrossRef
58.
Langouet M, Jolicoeur C, Javed A, Mattar P, Gearhart MD, Daiger SP, et al. Mutations in BCOR, a co-repressor of CRX/OTX2, are associated with early-onset retinal degeneration. Sci Adv. 2022;8(36):eabh868.CrossRef
59.
Kaufman ML, Goodson NB, Park KU, Schwanke M, Office E, Schneider SR, et al. Initiation of Otx2 expression in the developing mouse retina requires a unique enhancer and either Ascl1 or Neurog2 activity. Development. 2021;148(12).
60.
Pauly D, Agarwal D, Dana N, Schafer N, Biber J, Wunderlich KA, et al. Cell-type-specific complement expression in the healthy and diseased retina. Cell Rep. 2019;29(9):2835–3484.PubMedPubMedCentralCrossRef
61.
Davis CA, Hitz BC, Sloan CA, Chan ET, Davidson JM, Gabdank I, Hilton JA, Jain K, Baymuradov UK, Narayanan AK, Onate KC, Graham K, Miyasato SR, Dreszer TR, Strattan JS, Jolanki O, Tanaka FY, Cherry JM. The Encyclopedia of DNA elements (ENCODE): data portal update. Nucleic Acids Res. 2018;46(D1):D794-D801. https://​doi.​org/​10.​1093/​nar/​gkx1081.
62.
Mathelier A, Zhao X, Zhang AW, Parcy F, Worsley-Hunt R, Arenillas DJ, Buchman S, Chen CY, Chou A, Ienasescu H, Lim J, Shyr C, Tan G, Zhou M, Lenhard B, Sandelin A, Wasserman WW. JASPAR 2014: an extensively expanded and updated openaccess database of transcription factor binding profiles. Nucleic Acids Res. 2014;42(Database issue):D142-7. https://​doi.​org/​10.​1093/​nar/​gkt997.
63.
Rouillard AD, Gundersen GW, Fernandez NF, Wang Z, Monteiro CD, McDermott MG, Ma'ayan A. The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database (Oxford). 2016;2016:baw100. https://​doi.​org/​10.​1093/​database/​baw100.
64.
Macosko EZ, Basu A, Satija R, Nemesh J, Shekhar K, Goldman M, et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell. 2015;161(5):1202–14.PubMedPubMedCentralCrossRef
65.
Toops KA, Berlinicke C, Zack DJ, Nickells RW. Hydrocortisone stimulates neurite outgrowth from mouse retinal explants by modulating macroglial activity. Invest Ophthalmol Vis Sci. 2012;53(4):2046–61.PubMedPubMedCentralCrossRef
66.
Bringmann A, Pannicke T, Biedermann B, Francke M, Iandiev I, Grosche J, et al. Role of retinal glial cells in neurotransmitter uptake and metabolism. Neurochem Int. 2009;54(3–4):143–60.PubMedCrossRef
67.
Poitry S, Poitry-Yamate C, Ueberfeld J, MacLeish PR, Tsacopoulos M. Mechanisms of glutamate metabolic signaling in retinal glial (Muller) cells. J Neurosci. 2000;20(5):1809–21.PubMedPubMedCentralCrossRef
68.
Reynisson H, Kalloniatis M, Fletcher EL, Shivdasani MN, Nivison-Smith L. Loss of Muller cell glutamine synthetase immunoreactivity is associated with neuronal changes in late-stage retinal degeneration. Front Neuroanat. 2023;17: 997722.PubMedPubMedCentralCrossRef
69.
Pannicke T, Frommherz I, Biedermann B, Wagner L, Sauer K, Ulbricht E, et al. Differential effects of P2Y1 deletion on glial activation and survival of photoreceptors and amacrine cells in the ischemic mouse retina. Cell Death Dis. 2014;5: e1353.PubMedPubMedCentralCrossRef
70.
Reichenbach A, Wurm A, Pannicke T, Iandiev I, Wiedemann P, Bringmann A. Muller cells as players in retinal degeneration and edema. Graefes Arch Clin Exp Ophthalmol. 2007;245(5):627–36.PubMedCrossRef
71.
72.
Arroba AI, Alcalde-Estevez E, Garcia-Ramirez M, Cazzoni D, de la Villa P, Sanchez-Fernandez EM, et al. Modulation of microglia polarization dynamics during diabetic retinopathy in db/db mice. Biochim Biophys Acta. 2016;1862(9):1663–74.PubMedCrossRef
73.
Bogdanov P, Corraliza L, Villena JA, Carvalho AR, Garcia-Arumi J, Ramos D, et al. The db/db mouse: a useful model for the study of diabetic retinal neurodegeneration. PLoS ONE. 2014;9(5): e97302.ADSPubMedPubMedCentralCrossRef
74.
Church KA, Rodriguez D, Mendiola AS, Vanegas D, Gutierrez IL, Tamayo I, et al. Pharmacological depletion of microglia alleviates neuronal and vascular damage in the diabetic CX3CR1-WT retina but not in CX3CR1-KO or hCX3CR1(I249/M280)-expressing retina. Front Immunol. 2023;14:1130735.PubMedPubMedCentralCrossRef
75.
Azrad-Leibovich T, Zahavi A, Gohas MF, Brookman M, Barinfeld O, Muhsinoglu O, et al. Characterization of diabetic retinopathy in two mouse models and response to a single injection of anti-vascular endothelial growth factor. Int J Mol Sci. 2022;24(1):324.PubMedPubMedCentralCrossRef
76.
Krugel K, Wurm A, Pannicke T, Hollborn M, Karl A, Wiedemann P, et al. Involvement of oxidative stress and mitochondrial dysfunction in the osmotic swelling of retinal glial cells from diabetic rats. Exp Eye Res. 2011;92(1):87–93.PubMedCrossRef
77.
Alvarez Y, Chen K, Reynolds AL, Waghorne N, O’Connor JJ, Kennedy BN. Predominant cone photoreceptor dysfunction in a hyperglycaemic model of non-proliferative diabetic retinopathy. Dis Model Mech. 2010;3(3–4):236–45.PubMedCrossRef
78.
Cho NC, Poulsen GL, Ver Hoeve JN, Nork TM. Selective loss of S-cones in diabetic retinopathy. Arch Ophthalmol. 2000;118(10):1393–400.PubMedCrossRef
79.
McAnany JJ, Park JC. Cone photoreceptor dysfunction in early-stage diabetic retinopathy: association between the activation phase of cone phototransduction and the flicker electroretinogram. Invest Ophthalmol Vis Sci. 2019;60(1):64–72.PubMedPubMedCentralCrossRef
80.
Di R, Luo Q, Mathew D, Bhatwadekar AD. Diabetes alters diurnal rhythm of electroretinogram in db/db mice. Yale J Biol Med. 2019;92(2):155–67.PubMedPubMedCentral
81.
Samuels IS, Bell BA, Pereira A, Saxon J, Peachey NS. Early retinal pigment epithelium dysfunction is concomitant with hyperglycemia in mouse models of type 1 and type 2 diabetes. J Neurophysiol. 2015;113(4):1085–99.PubMedCrossRef
82.
McDowell RE, McGahon MK, Augustine J, Chen M, McGeown JG, Curtis TM. Diabetes impairs the aldehyde detoxifying capacity of the retina. Invest Ophthalmol Vis Sci. 2016;57(11):4762–71.PubMedCrossRef
83.
Pan HZ, Zhang H, Chang D, Li H, Sui H. The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthalmol. 2008;92(4):548–51.PubMedCrossRef
84.
Augustine J, Troendle EP, Barabas P, McAleese CA, Friedel T, Stitt AW, et al. The role of lipoxidation in the pathogenesis of diabetic retinopathy. Front Endocrinol (Lausanne). 2020;11: 621938.PubMedCrossRef
85.
Jennings CL, Saadane A, Leinonen H, Elliot HC, Gao F, Lewandowski D, et al. Stress resilience-enhancing drugs preserve tissue structure and function in degenerating retina via phosphodiesterase inhibition. Proc Natl Acad Sci USA. 2023;120(19): e2221045120.CrossRef
86.
Van Hove I, De Groef L, Boeckx B, Modave E, Hu TT, Beets K, et al. Single-cell transcriptome analysis of the Akimba mouse retina reveals cell-type-specific insights into the pathobiology of diabetic retinopathy. Diabetologia. 2020;63(10):2235–48.PubMedCrossRef
87.
Ly A, Scheerer MF, Zukunft S, Muschet C, Merl J, Adamski J, et al. Retinal proteome alterations in a mouse model of type 2 diabetes. Diabetologia. 2014;57(1):192–203.PubMedCrossRef
88.
Kandpal RP, Rajasimha HK, Brooks MJ, Nellissery J, Wan J, Qian J, et al. Transcriptome analysis using next generation sequencing reveals molecular signatures of diabetic retinopathy and efficacy of candidate drugs. Mol Vis. 2012;18:1123–46.PubMedPubMedCentral
89.
Grant MB, Afzal A, Spoerri P, Pan H, Shaw LC, Mames RN. The role of growth factors in the pathogenesis of diabetic retinopathy. Expert Opin Investig Drugs. 2004;13(10):1275–93.PubMedCrossRef
90.
Kjell J, Fischer-Sternjak J, Thompson AJ, Friess C, Sticco MJ, Salinas F, et al. Defining the adult neural stem cell niche proteome identifies key regulators of adult neurogenesis. Cell Stem Cell. 2020;26(2):277-93 e8.PubMedPubMedCentralCrossRef
91.
Vogel C, Marcotte EM. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet. 2012;13(4):227–32.PubMedPubMedCentralCrossRef
92.
Liu Y, Beyer A, Aebersold R. On the dependency of cellular protein levels on mRNA abundance. Cell. 2016;165(3):535–50.PubMedCrossRef
93.
Imai S, Otsuka T, Naito A, Shimazawa M, Hara H. Triamcinolone acetonide suppresses inflammation and facilitates vascular barrier function in human retinal microvascular endothelial cells. Curr Neurovasc Res. 2017;14(3):232–41.PubMedCrossRef
94.
Stewart EA, Saker S, Amoaku WM. Dexamethasone reverses the effects of high glucose on human retinal endothelial cell permeability and proliferation in vitro. Exp Eye Res. 2016;151:75–81.PubMedCrossRef
95.
Sulaiman RS, Kadmiel M, Cidlowski JA. Glucocorticoid receptor signaling in the eye. Steroids. 2018;133:60–6.PubMedCrossRef
96.
Wenzel A, Grimm C, Samardzija M, Reme CE. The genetic modifier Rpe65Leu(450): effect on light damage susceptibility in c-Fos-deficient mice. Invest Ophthalmol Vis Sci. 2003;44(6):2798–802.PubMedCrossRef
97.
Wenzel A, Grimm C, Seeliger MW, Jaissle G, Hafezi F, Kretschmer R, et al. Prevention of photoreceptor apoptosis by activation of the glucocorticoid receptor. Invest Ophthalmol Vis Sci. 2001;42(7):1653–9.PubMed
98.
Zhang X, Lai D, Bao S, Hambly BD, Gillies MC. Triamcinolone acetonide inhibits p38MAPK activation and neuronal apoptosis in early diabetic retinopathy. Curr Mol Med. 2013;13(6):946–58.PubMedCrossRef
99.
100.
Erickson RL, Browne CA, Lucki I. Hair corticosterone measurement in mouse models of type 1 and type 2 diabetes mellitus. Physiol Behav. 2017;178:166–71.PubMedPubMedCentralCrossRef
101.
Kadmiel M, Ramamoorthy S, Cidlowski J. Glucocorticoid receptor role in the mouse retina. Investig Ophthalmol Vis Sci. 2015;56(7):887.
102.
Ghaseminejad F, Kaplan L, Pfaller AM, Hauck SM, Grosche A. The role of Muller cell glucocorticoid signaling in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2020;258(2):221–30.PubMedCrossRef
103.
104.
Ma S, Meng Z, Chen R, Guan KL. The hippo pathway: biology and pathophysiology. Annu Rev Biochem. 2019;88:577–604.PubMedCrossRef
105.
Hamon A, Garcia-Garcia D, Ail D, Bitard J, Chesneau A, Dalkara D, et al. Linking YAP to muller glia quiescence exit in the degenerative retina. Cell Rep. 2019;27(6):1712–25.PubMedCrossRef
106.
Rueda EM, Hall BM, Hill MC, Swinton PG, Tong X, Martin JF, et al. The hippo pathway blocks mammalian retinal Muller glial cell reprogramming. Cell Rep. 2019;27(6):1637–2496.PubMedPubMedCentralCrossRef
107.
Kim SL, Choi HS, Kim JH, Lee DS. The antiasthma medication ciclesonide suppresses breast cancer stem cells through inhibition of the glucocorticoid receptor signaling-dependent YAP pathway. Molecules. 2020;25(24):6028.PubMedPubMedCentralCrossRef
108.
Sorrentino G, Ruggeri N, Zannini A, Ingallina E, Bertolio R, Marotta C, et al. Glucocorticoid receptor signalling activates YAP in breast cancer. Nat Commun. 2017;8:14073.ADSPubMedPubMedCentralCrossRef
109.
Peng C, Zhu Y, Zhang W, Liao Q, Chen Y, Zhao X, et al. Regulation of the Hippo-YAP Pathway by Glucose Sensor O-GlcNAcylation. Mol Cell. 2017;68(3):591-604 e5.PubMedCrossRef
110.
Zhang X, Qiao Y, Wu Q, Chen Y, Zou S, Liu X, et al. The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesis. Nat Commun. 2017;8:15280.ADSPubMedPubMedCentralCrossRef
111.
Wu Y, Pan Q, Yan H, Zhang K, Guo X, Xu Z, et al. Novel mechanism of foxo1 phosphorylation in glucagon signaling in control of glucose homeostasis. Diabetes. 2018;67(11):2167–82.PubMedPubMedCentralCrossRef
112.
Yang Z, Alvarez BV, Chakarova C, Jiang L, Karan G, Frederick JM, et al. Mutant carbonic anhydrase 4 impairs pH regulation and causes retinal photoreceptor degeneration. Hum Mol Genet. 2005;14(2):255–65.PubMedCrossRef
113.
Wong TY, Cheung CM, Larsen M, Sharma S, Simo R. Diabetic retinopathy. Nat Rev Dis Primers. 2016;2:16012.PubMedCrossRef
114.
Arjomandnejad M, Dasgupta I, Flotte TR, Keeler AM. Immunogenicity of recombinant adeno-associated virus (AAV) vectors for gene transfer. BioDrugs. 2023;37(3):311–29.PubMedPubMedCentralCrossRef
115.
116.
Scholz R, Caramoy A, Bhuckory MB, Rashid K, Chen M, Xu H, et al. Targeting translocator protein (18 kDa) (TSPO) dampens pro-inflammatory microglia reactivity in the retina and protects from degeneration. J Neuroinflammation. 2015;12:201.PubMedPubMedCentralCrossRef
117.
Mages K, Grassmann F, Jagle H, Rupprecht R, Weber BHF, Hauck SM, et al. The agonistic TSPO ligand XBD173 attenuates the glial response thereby protecting inner retinal neurons in a murine model of retinal ischemia. J Neuroinflammation. 2019;16(1):43.PubMedPubMedCentralCrossRef
118.
Wang M, Wang X, Zhao L, Ma W, Rodriguez IR, Fariss RN, et al. Macroglia-microglia interactions via TSPO signaling regulates microglial activation in the mouse retina. J Neurosci. 2014;34(10):3793–806.PubMedPubMedCentralCrossRef
119.
Schmalen A, Lorenz L, Grosche A, Pauly D, Deeg CA, Hauck SM. Proteomic phenotyping of stimulated muller cells uncovers profound pro-inflammatory signaling and antigen-presenting capacity. Front Pharmacol. 2021;12: 771571.PubMedPubMedCentralCrossRef
120.
Kaczmarek-Hajek K, Zhang J, Kopp R, Grosche A, Rissiek B, Saul A, et al. Re-evaluation of neuronal P2X7 expression using novel mouse models and a P2X7-specific nanobody. Elife. 2018;7.
121.
Niu T, Fang J, Shi X, Zhao M, Xing X, Wang Y, et al. Pathogenesis study based on high-throughput single-cell sequencing analysis reveals novel transcriptional landscape and heterogeneity of retinal cells in type 2 diabetic mice. Diabetes. 2021;70(5):1185–97.PubMedCrossRef
122.
Peng BY, Wang Q, Luo YH, He JF, Tan T, Zhu H. A novel and quick PCR-based method to genotype mice with a leptin receptor mutation (db/db mice). Acta Pharmacol Sin. 2018;39(1):117–23.PubMedCrossRef
123.
Slezak M, Grosche A, Niemiec A, Tanimoto N, Pannicke T, Munch TA, et al. Relevance of exocytotic glutamate release from retinal glia. Neuron. 2012;74(3):504–16.PubMedCrossRef
124.
Uckermann O, Iandiev I, Francke M, Franze K, Grosche J, Wolf S, et al. Selective staining by vital dyes of Muller glial cells in retinal wholemounts. Glia. 2004;45(1):59–66.PubMedCrossRef
125.
Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676–82.PubMedCrossRef
126.
Chou JC, Rollins SD, Fawzi AA. Trypsin digest protocol to analyze the retinal vasculature of a mouse model. J Vis Exp. 2013;76: e50489.
127.
128.
Grassmann F. Conduct and quality control of differential gene expression analysis using high-throughput transcriptome sequencing (RNASeq). Methods Mol Biol. 2019;1834:29–43.PubMedCrossRef
129.
Kechin A, Boyarskikh U, Kel A, Filipenko M. cutPrimers: a new tool for accurate cutting of primers from reads of targeted next generation sequencing. J Comput Biol. 2017;24(11):1138–43.PubMedCrossRef
130.
131.
Corces MR, Trevino AE, Hamilton EG, Greenside PG, Sinnott-Armstrong NA, Vesuna S, et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nat Methods. 2017;14(10):959–62.PubMedPubMedCentralCrossRef
132.
Lun AT, Smyth GK. csaw: a Bioconductor package for differential binding analysis of ChIP-seq data using sliding windows. Nucleic Acids Res. 2016;44(5): e45.PubMedCrossRef
133.
Machlab D, Burger L, Soneson C, Rijli FM, Schubeler D, Stadler MB. monaLisa: an R/Bioconductor package for identifying regulatory motifs. Bioinformatics. 2022;38(9):2624–5.PubMedPubMedCentralCrossRef
134.
Frik J, Merl-Pham J, Plesnila N, Mattugini N, Kjell J, Kraska J, et al. Cross-talk between monocyte invasion and astrocyte proliferation regulates scarring in brain injury. EMBO Rep. 2018;19(5).
135.
Perez-Riverol Y, Bai J, Bandla C, Garcia-Seisdedos D, Hewapathirana S, Kamatchinathan S, et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 2022;50(D1):D543–52.PubMedCrossRef
Metadata
Title
The glucocorticoid receptor as a master regulator of the Müller cell response to diabetic conditions in mice
Authors
Anna M. Pfaller
Lew Kaplan
Madalena Carido
Felix Grassmann
Nundehui Díaz-Lezama
Farhad Ghaseminejad
Kirsten A. Wunderlich
Sarah Glänzer
Oliver Bludau
Thomas Pannicke
Bernhard H. F. Weber
Susanne F. Koch
Boyan Bonev
Stefanie M. Hauck
Antje Grosche
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Journal of Neuroinflammation / Issue 1/2024
Electronic ISSN: 1742-2094
DOI
https://doi.org/10.1186/s12974-024-03021-x

Other articles of this Issue 1/2024

Journal of Neuroinflammation 1/2024 Go to the issue

Research

Impaired cerebral microvascular endothelial cells integrity due to elevated dopamine in myasthenic model

Research

Nigrostriatal degeneration determines dynamics of glial inflammatory and phagocytic activity

Review

The contribution of the meningeal immune interface to neuroinflammation in traumatic brain injury

Research

Impact of microglia isolation and culture methodology on transcriptional profile and function

Research

Itaconate alleviates anesthesia/surgery-induced cognitive impairment by activating a Nrf2-dependent anti-neuroinflammation and neurogenesis via gut-brain axis

Review

MIF contribution to progressive brain diseases